Saturday, November 5, 2016

Proposed Revisions to USP 797 – Overview and Current Status

Proposed Revisions to USP 797 – Overview and Current Status , see:   


Follow Bernstein & Associates, Architects:
Pharmacy Architecture and Design: http://bernarch.com/healthcare-design-pharmacy/
Bernstein & Associates, Architects on Twitter: https://twitter.com/bernsteinarch
Bernstein & Associates, Architects on Blogger: http://bernarch.blogspot.com/
Bernstein & Associates, Architects on LinkedIn: https://www.linkedin.com/company/bernstein-&-associates-architects
Bernstein & Associates, Architects on Facebook: https://www.facebook.com/bernsteinarchitects/

Follow Empire Projects, Inc.:
Healthcare project management services, see: http://empireprojects.com/healthcare-project-management/
Hospital project management services, see: http://empireprojects.com/healthcare-project-management-hospitals/
Empire Projects, Inc. on Twitter: https://twitter.com/empireprojects
Empire Projects, Inc.on Blogger: http://empireprojects.blogspot.com/
Empire Projects, Inc. on LinkedIn: https://www.linkedin.com/company/empire-projects-inc.
Empire Projects, Inc. on Facebook: https://www.facebook.com/empireprojectsusa/

Follow USP.org:

Follow USP800.guru:
USP800.guru on Twitter: https://www.twitter.com/usp800
USP800.org on Blogger: http://usp800.blogspot.com/
USP800.org on Facebook:  https://www.facebook.com/USP800

Follow USP797.org:
USP797.org on Twitter: https://www.twitter.com/usp797
USP797.org on Blogger: http://usp797org.blogspot.com/
USP797.org on Facebook: https://www.facebook.com/usp797
PharmacyDesign.org on Twitter: https://twitter.com/pharmacydesign
PharmacyDesign.org on Blogger: http://pharmacydesigns.blogspot.com/
PharmacyDesign.org on LinkedIn: https://www.linkedin.com/company/pharmacy-design
PharmacyDesign.org on Facebook: https://www.facebook.com/pharmacydesigns/

To reach USP800.guru:
1483 York Avenue - #20602
New York, NY 10021
T: 800-974-3109

Friday, November 4, 2016

USP 800 Pharmacy Design – New Article Published by Pharmacy Architect

A new article on creating a USP 800 compliant pharmacy, by William N. Bernstein, AIA, has just been published in Health Facilities Management.

Entitled “USP 800 Brings New Regulations to Hospital Pharmacies”, the article is a comprehensive guide to designing clean room environments for sterile compounding and non-sterile compounding in accordance with the new USP 800 guidelines.

The full pharmacy design article can be found at http://www.hfmmagazine.com/articles/2526-handling-hazardous-drugs-in-health-care

Below are some of the topics covered in this USP 800 article:
History of USP 800
Deadline for compliance with USP 800
Relationship of USP 797 and USP 800
Changes in guidelines on sterile compounding of hazardous drugs relative to previous guidelines in USP 797
What does USP 800 mean when it refers to “hazardous drugs”
Latest list of USP 800 hazardous drugs
Frequency of review of list of USP 800 hazardous drugs
Introducing new hazardous drugs in a USP 800 compliant facility
Exceptions to list of USP 800 hazardous drugs
Discussion of investigational drugs in USP 800 guideline
Under what circumstances do hazardous drugs fall outside of USP 800 guidelines
Discussion of “assessment of risk” in USP 800 guidelines
Areas governed by USP 800
How does USP 800 address storage of hazardous drugs
How does USP 800 address compounding of hazardous drugs
When is a negative pressure room required under USP 800
How many air changes does USP 800 require
What additional space does USP 800 require
How does USP 800 address refrigeration of hazardous drugs
Locations of refrigerated storage of hazardous drugs in USP 800
Location of exhaust relative to refrigerator in USP 800
Discussion of details of storage room shelving in USP 800
Seismic considerations discussed in USP 800
Discussion of which drugs go into the USP 800 storage room
Storage of sterile and non-sterile hazardous drugs in USP 800
Under what circumstances can sterile and non-sterile drugs be stored in the same room in USP 800
Discussion of compounding vs. fixed formulations in USP 800
Types of controls related to the compounding process in USP 800
C-PEC in USP 800
C-SEC in USP 800
Closed-system, drug transfer device in USP 800
When is an ISO-5 environment required in USP 800
When is an ISO-7 environment required in USP 800
When is a negative-pressure room required in USP 800
USP 800 discussion of loss of power
USP 800 discussion of emergency power
Discussion of worker safety in USP 800
Types of Biosafety Cabinets discussed in USP 800
USP 800 eliminates available options that existed in USP 797
USP 800 discussion of signage
Location of spaces discussed in USP 800
Receipt and unpacking of hazardous drugs as discussed in USP 800
Water column measurements in USP 800
What has to be externally vented in a USP 800 compliant pharmacy
Air exchange rate requirements in USP 800
USP 800 discussion of maintaining power to ventilation systems in a power outage
Different USP 800 requirements for sterile compounding vs. non-sterile compounding
Definition of non-sterile compounding in USP 800
Definition of sterile compounding in USP 800
Under what circumstances does USP 800 permit both sterile and nonsterile compounding in the same room
Under what circumstances does USP 800 permit sterile compounding in a non-ISO space
USP 800 discussion of segregated compounding area (C-SCA).
USP 800 requirements for non-sterile compounding
Carry-over of certain requirements from USP 797 in terms of cleanroom design in USP 800
Discussion of USP 795, Pharmaceutical Compounding — Nonsterile Preparations, in USP 800
Under what circumstances does USP 800 permit sterile and nonsterile compounding in the same room
Relationship of storage and compounding spaces in USP 800

Author of this USP 800 article is William N. Bernstein, LEED AP, AIA, the principal of Bernstein & Associates Architects. His firm has been at the forefront of designing USP 797 and USP 800 compliant  pharmacies across the US. He can be reached at info@bernarch.com.

Follow Bernstein & Associates, Architects:
Pharmacy Architecture and Design: http://bernarch.com/healthcare-design-pharmacy/
USP 797 Architecture and Design: http://bernarch.com/healthcare-design-usp-797-compliant-pharmacy-design-and-consulting/
USP 800 Architecture and Design: http://bernarch.com/healthcare-design-usp-800-compliant-pharmacy-design-and-consulting/
Bernstein & Associates, Architects on Twitter: https://twitter.com/bernsteinarch
Bernstein & Associates, Architects on Blogger: http://bernarch.blogspot.com/
Bernstein & Associates, Architects on LinkedIn: https://www.linkedin.com/company/bernstein-&-associates-architects
Bernstein & Associates, Architects on Facebook: https://www.facebook.com/bernsteinarchitects/

Follow Empire Projects, Inc.:
Healthcare project management services, see: http://empireprojects.com/healthcare-project-management/
Hospital project management services, see: http://empireprojects.com/healthcare-project-management-hospitals/
Empire Projects, Inc. on Twitter: https://twitter.com/empireprojects
Empire Projects, Inc.on Blogger: http://empireprojects.blogspot.com/
Empire Projects, Inc. on LinkedIn: https://www.linkedin.com/company/empire-projects-inc.
Empire Projects, Inc. on Facebook: https://www.facebook.com/empireprojectsusa/

Follow USP.org:
USP.org on Twitter: https://twitter.com/uspharmacopeia
USP.org Blog: http://qualitymatters.usp.org/
USP.org on LinkedIn: https://www.linkedin.com/company/uspharmacopeia
USP.org on Facebook: https://www.facebook.com/USPharmacopeia

Follow USP800.guru:
USP800.guru on Twitter: https://www.twitter.com/usp800
USP800.org on Blogger: http://usp800.blogspot.com/
USP800.org on LinkedIn: https://www.linkedin.com/company/usp800-guru
USP800.org on Facebook:  https://www.facebook.com/USP800

Follow USP797.org:
USP797.org on Twitter: https://www.twitter.com/usp797
USP797.org on Blogger: http://usp797org.blogspot.com/
USP797.org on LinkedIn: https://www.linkedin.com/company/usp797-org-inc-
USP797.org on Facebook: https://www.facebook.com/usp797

Follow PharmacyDesign.org:
PharmacyDesign.org on Twitter: https://twitter.com/pharmacydesign
PharmacyDesign.org on Blogger: http://pharmacydesigns.blogspot.com/
PharmacyDesign.org on LinkedIn: https://www.linkedin.com/company/pharmacy-design
PharmacyDesign.org on Facebook: https://www.facebook.com/pharmacydesigns/

To reach USP800.guru:
USP800.guru
1483 York Avenue - #20602
New York, NY 10021
T: 800-974-3109
E: info@usp800.guru 
W: www.usp800.guru 

Thursday, October 27, 2016

USP 800 - Frequently Asked Questions (FAQs) Updated in September 2016

The United States Pharmacopeia (USP) --- the scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide" such as USP 797 and USP 800, has recently their FAQs for <800>.


The updated list of USP 800 FAQ's is available at http://www.usp.org/frequently-asked-questions/hazardous-drugs-handling-healthcare-settings.
The <800> FAQs were last updated on the USP website on September 15, 2016.
Below is the list of USP 800 questions that are answered in the above link:
What is a hazardous drug?
Additional Resources:
Follow USP.org:
USP.org on Twitter: https://twitter.com/uspharmacopeia
Follow USP800.guru:
USP800.guru on Twitter: https://www.twitter.com/usp800
Follow USP797.org:
USP797.org on Twitter: https://www.twitter.com/usp797
Follow PharmacyDesign.org:
PharmacyDesign.org on Twitter: https://twitter.com/pharmacydesign
To reach USP800.guru:
USP800.guru




What is the purpose of this chapter?
Who enforces the chapter?
Who does the chapter apply to?
What settings does the chapter apply to?
Does the chapter apply to administration of HDs?
What is the status of the General Chapter <800> and when will General Chapter <800> become official?
Will there be updates or changes to the chapter?
How can I obtain a copy of General Chapter <800>?
Have there been any documented/published studies involving harm related to handling of HDs?
Where does the designated person obtain training? How much training does the designated person need?
Are there requirement for posting signs that HDs are being handled in the facility?
Can sterile and nonsterile HDs be stored together?
Can refrigerated non-antineoplastic HDs be stored with antineoplastic HDs?
Where should the sink be located?
Can non-HDs and HDs be compounded in C-PECs located in the same C-SEC?
Can a Laminar Airflow Workbench (LAFW) or compounding aseptic isolator (CAI) be used for compounding a non-antineoplastic HD?
Can a BSC or CACI used for compounding HDs be used for compounding non-HDs?
Is there an evaluation tool one can use for evaluating the performance of the different closed-system drug-transfer devices (CSTDs) available?
How can a closed-system drug-transfer device (CSTD) be chemically incompatible with a HD?
What is meant by "fixed walls"?
Are pressure gauges required to monitor the pressure differential between the C-SEC and the adjacent areas?
Is environmental wipe sampling required?
Why is environmental wipe sampling recommended when there is currently no standard for acceptable limits on HD surface contamination?
What are the acceptable limits for HD surface contamination?
Are compounders required to remove all PPE when leaving the compounding area?
Can gowns be re-worn during the same day if a compounder leaves the HD compounding area?
What documentation is required to show that a gown will resist permeability by HDs?
Where should HD APIs be handled prior to sterilization when compounding sterile HDs?
Does the chapter apply if the HD is dissolved in a liquid dosage form and does not become an aerosol or 
If the HD is a liquid dosage form, may it be compounded in a positive pressure non-HD cleanroom?
Do personnel of reproductive capability include both male and females?
Does the HD return waiting area have to be separate from the regular HD storage area?
What container materials are considered impervious?
What is the tiered approach for receiving HDs?
What must be on the label for HDs?
What kind of packaging containers can be used for packaging HDs?
Can HDs be transported in pneumatic tubes, robots, or patient carts?
Are personnel involved in waste removal and cleaning required to don PPE?
What if the employee wants to keep their medical records private from the employer?
What "health variables" should be followed over time for individual workers?
In a medical surveillance program, how does an employer obtain data from the unexposed workers for comparison to the exposed workers?



USP.org Blog: http://qualitymatters.usp.org/
USP.org on LinkedIn: https://www.linkedin.com/company/uspharmacopeia
USP.org on Facebook: https://www.facebook.com/USPharmacopeia


USP800.org on Blogger: http://usp800.blogspot.com/
USP800.org on LinkedIn: https://www.linkedin.com/company/usp800-guru
USP800.org on Facebook:  https://www.facebook.com/USP800


USP797.org on Blogger: http://usp797org.blogspot.com/
USP797.org on LinkedIn: https://www.linkedin.com/company/usp797-org-inc-
USP797.org on Facebook: https://www.facebook.com/usp797

PharmacyDesign.org on Blogger: http://pharmacydesigns.blogspot.com/
PharmacyDesign.org on LinkedIn: https://www.linkedin.com/company/pharmacy-design
PharmacyDesign.org on Facebook: https://www.facebook.com/pharmacydesigns/

USP 800
1483 York Avenue - #20602
New York, NY 10021
T: 800-974-3109
E: info@usp800.guru 
W: www.usp800.guru 


USP 800 Hazardous Drugs - New List Published

USP 800 governs the handling of hazardous drugs. But what drugs does USP 800 define as hazardous?

The list of hazardous drugs referred to in USP 800 is the list published by the National Institute for Occupational Safety and Health (NIOSH). The list is entitled “NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings".

This list of hazardous drugs was first published in September 2004. It was updated in 2010 and 2012. The latest version of this list was published in September 2016.

To download a copy of the latest list of hazardous drugs, as of the date of this article, published by NIOSH, which are the hazardous drugs referred to in USP 800, go to:
http://www.cdc.gov/niosh/topics/antineoplastic/pdf/hazardous-drugs-list_2016-161.pdf

Additional Resources:

Follow USP800.guru:

USP800.guru on Twitter: https://www.twitter.com/usp800
USP800.org on Blogger: http://usp800.blogspot.com/
USP800.org on LinkedIn: https://www.linkedin.com/company/usp800-guru
USP800.org on Facebook:  https://www.facebook.com/USP800

Follow USP797.org:

USP797.org on Twitter: https://www.twitter.com/usp797
USP797.org on Blogger: http://usp797org.blogspot.com/
USP797.org on LinkedIn: https://www.linkedin.com/company/usp797-org-inc-
USP797.org on Facebook: https://www.facebook.com/usp797

Follow PharmacyDesign.org:

PharmacyDesign.org on Twitter: https://twitter.com/pharmacydesign
PharmacyDesign.org on Blogger: http://pharmacydesigns.blogspot.com/
PharmacyDesign.org on LinkedIn: https://www.linkedin.com/company/pharmacy-design
PharmacyDesign.org on Facebook: https://www.facebook.com/pharmacydesigns/

To reach USP800.guru:

USP800.guru
1483 York Avenue - #20602
New York, NY 10021
T: 800-974-3109
E: info@usp800.guru 
W: www.usp800.guru 

USP 800 Architectural Design Article to be Published

Bernstein & Associates, Architects is pleased to announce that an article written by the firm's principle, William N. Bernstein, AIA, on the architectural and engineering design of USP 800 compliant spaces, is scheduled for publication in November 2016. 

Further details on the article will be provided when the article is published. 

Bernstein & Associates, Architects has been on the vanguard of understanding and implementing the USP 797 guidelines since 2005, and the draft USP 800 guidelines since 2014. The firm has designed over (25) USP 797 compliant pharmacies and currently has (5) USP 800 compliant compounding suites that are in the design phase.  

For further information on USP 800 architectural design, please see http://bernarch.com/healthcare-design-usp-800-compliant-pharmacy-design-and-consulting/

For further information on USP 800 architectural design, please see http://bernarch.com/healthcare-design-usp-797-compliant-pharmacy-design-and-consulting/

For further information on pharmacy design, please see http://bernarch.com/healthcare-design-pharmacy/

Additional Resources:

Follow Bernstein & Associates, Architects:

Bernstein & Associates, Architects on Twitter: https://twitter.com/bernsteinarch
Bernstein & Associates, Architects on Blogger: http://bernarch.blogspot.com/
Bernstein & Associates, Architects on LinkedIn: https://www.linkedin.com/company/bernstein-&-associates-architects
Bernstein & Associates, Architects on Facebook: https://www.facebook.com/bernsteinarchitects/

Follow USP800.guru:

USP800.guru on Twitter: https://www.twitter.com/usp800
USP800.org on Blogger: http://usp800.blogspot.com/
USP800.org on LinkedIn: https://www.linkedin.com/company/usp800-guru
USP800.org on Facebook:  https://www.facebook.com/USP800

Follow USP797.org:

USP797.org on Twitter: https://www.twitter.com/usp797
USP797.org on Blogger: http://usp797org.blogspot.com/
USP797.org on LinkedIn: https://www.linkedin.com/company/usp797-org-inc-
USP797.org on Facebook: https://www.facebook.com/usp797

Follow PharmacyDesign.org:

PharmacyDesign.org on Twitter: https://twitter.com/pharmacydesign
PharmacyDesign.org on Blogger: http://pharmacydesigns.blogspot.com/
PharmacyDesign.org on LinkedIn: https://www.linkedin.com/company/pharmacy-design
PharmacyDesign.org on Facebook: https://www.facebook.com/pharmacydesigns/

To reach USP800.guru:

USP800.guru
1483 York Avenue - #20602
New York, NY 10021
T: 800-974-3109
E: info@usp800.guru 
W: www.usp800.guru 


Sunday, July 10, 2016

Deadline for Implementation of USP 800

USP has established a deadline for implementation of USP 800. Here is the information from USP:

"General Chapter <800> was published on February 1, 2016 in the First Supplement to USP 39–NF 34.The Expert Committee approved a delayed official implementation date of July 1, 2018 to allow entities additional time to implement the standard. With the delayed official date, entities have more than two years to implement this new standard."


Following is some additional key information about the USP 800 guidelines from USP: (http://www.usp.org/frequently-asked-questions/hazardous-drugs-handling-healthcare-settings):


What is the purpose of General Chapter <800>?
The purpose of the chapter is to describe practice and quality standards for handling hazardous drugs in healthcare settings and help promote patient safety, worker safety, and environmental protection. The new general chapter defines processes intended to minimize the exposure to hazardous drugs in healthcare settings.

Does General Chapter <800> apply to me?
The chapter applies to all healthcare personnel who handle hazardous drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, physician assistants, home healthcare workers, veterinarians, and veterinary technicians). The chapter also covers all healthcare entities that store, prepare, transport, or administer hazardous drugs (e.g., pharmacies, hospitals, other healthcare institutions, patient treatment clinics, physicians’ practice facilities, and veterinarian offices).

What is a hazardous drug?
A hazardous drug is any drug identified as hazardous or potentially hazardous by the National Institute for Occupational Safety and Health (NIOSH) on the basis of at least one of the following six criteria: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity in humans, organ toxicity at low doses in humans or animals, genotoxicity, and new drugs that mimic existing hazardous drugs in structure or toxicity. NIOSH maintains a list of antineoplastic and other hazardous drugs used in healthcare settings.

What is the status of the General Chapter <800> and when will General Chapter <800> become official?
General Chapter <800> was published on February 1, 2016 in the First Supplement to USP 39–NF 34.The Expert Committee approved a delayed official implementation date of July 1, 2018 to allow entities additional time to implement the standard. With the delayed official date, entities have more than two years to implement this new standard.

How can I obtain a copy of General Chapter <800>?
General Chapter <800> was published on February 1, 2016 in the First Supplement to USP 39–NF 34. You may purchase the chapter through a subscription to the USP Compounding Compendium or USP-NF.

Ways to Follow USP800.guru:

USP800.guru on Twitter: https://www.twitter.com/usp800
USP800.org on Blogger: http://usp800.blogspot.com/
USP800.org on LinkedIn: https://www.linkedin.com/company/usp800-guru
USP800.org on Facebook:  https://www.facebook.com/USP800

Ways to Follow USP797.org:

USP797.org on Twitter: https://www.twitter.com/usp797
USP797.org on Blogger: http://usp797org.blogspot.com/
USP797.org on LinkedIn: https://www.linkedin.com/company/usp797-org-inc-
USP797.org on Facebook: https://www.facebook.com/usp797

To reach USP800.guru:

USP800.guru
1201 Broadway - #803
New York, NY 10001
T: 800-974-3109
E: info@usp800.guru
W: www.usp800.guru